ÂÜÀòÂÒÂ×

Rizwan Manzer is an accomplished professional in the biopharmaceutical industry with extensive experience in CMC and technical operations. Currently serving as Director of CMC and Technical Operations at Vigil Neuroscience since August 2020, Rizwan has held significant roles at various organizations, including Director CMC at Verseau Therapeutics and Director of Bioprocessing at CuriRx Inc. Prior experience includes Associate Director Cell Line & Technology at Batavia Biosciences and Principal Scientist at Merrimack Pharmaceuticals. Rizwan's career began as a Senior Researcher at National Jewish Health and a Visiting Research Fellow at the University of Colorado Health Sciences Center. Rizwan holds an MBA in Strategic Business Planning from the University of Denver, a Post Doctoral Fellowship in Molecular Toxicology from the University of Colorado Anschutz Medical Campus, and an MD from JN Medical College, Aligarh Muslim University.